JP2010508242A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010508242A5 JP2010508242A5 JP2009527656A JP2009527656A JP2010508242A5 JP 2010508242 A5 JP2010508242 A5 JP 2010508242A5 JP 2009527656 A JP2009527656 A JP 2009527656A JP 2009527656 A JP2009527656 A JP 2009527656A JP 2010508242 A5 JP2010508242 A5 JP 2010508242A5
- Authority
- JP
- Japan
- Prior art keywords
- prooxidant
- compound
- methyl
- vitamin
- analog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2006905109 | 2006-09-15 | ||
| AU2006905109A AU2006905109A0 (en) | 2006-09-15 | Pro-oxidant Anti-cancer Compounds | |
| PCT/AU2007/001371 WO2008031171A1 (en) | 2006-09-15 | 2007-09-17 | Pro-oxidant anti-cancer compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010508242A JP2010508242A (ja) | 2010-03-18 |
| JP2010508242A5 true JP2010508242A5 (enExample) | 2013-03-28 |
| JP5396274B2 JP5396274B2 (ja) | 2014-01-22 |
Family
ID=39183283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009527656A Expired - Fee Related JP5396274B2 (ja) | 2006-09-15 | 2007-09-17 | プロオキシダント抗ガン化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8410056B2 (enExample) |
| EP (1) | EP2063884B1 (enExample) |
| JP (1) | JP5396274B2 (enExample) |
| KR (1) | KR101482803B1 (enExample) |
| AU (1) | AU2007295877B2 (enExample) |
| CA (1) | CA2663474C (enExample) |
| NZ (1) | NZ575920A (enExample) |
| WO (1) | WO2008031171A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2734208C (en) | 2008-03-14 | 2018-01-09 | Jiri Neuzil | Mitochondrially delivered anti-cancer compounds |
| JP2012523458A (ja) * | 2009-04-13 | 2012-10-04 | ザ オハイオ ステート ユニバーシティー リサーチ ファウンデーション | タンパク質ホスファターゼ２ａ活性化剤 |
| CN102439453A (zh) | 2009-05-20 | 2012-05-02 | 日内瓦大学 | 癌症起始细胞的线粒体活性抑制剂及其用途 |
| PT3122757T (pt) * | 2014-02-28 | 2023-11-03 | Hangzhou Dac Biotech Co Ltd | Ligantes carregados e as suas utilizações em conjugação |
| US11007182B2 (en) | 2015-04-09 | 2021-05-18 | Health Research, Inc. | Use of atpenin to activate innate immunity |
| KR102644587B1 (ko) * | 2015-12-24 | 2024-03-07 | (주)아모레퍼시픽 | 유사 세라마이드 화합물 및 그 제조방법 |
| EP3580328A4 (en) * | 2017-02-10 | 2020-12-30 | Health Research, Inc. | TARGETING MITOCHONDRIAL II COMPLEX TO REDUCE THE EFFECTS OF CHRONIC HYPOXIA |
| US20210205264A1 (en) * | 2018-09-04 | 2021-07-08 | H. Lee Moffitt Cancer Center & Research Institute Inc. | Use of delta-tocotrienol for treating cancer |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2220541A1 (en) | 1997-11-07 | 1999-05-07 | Mcgill University | Analogs of vitamin e |
| RU2191903C2 (ru) | 1998-07-21 | 2002-10-27 | Карпенко Анатолий Григорьевич | Глушитель шума выхлопа двигателя внутреннего сгорания |
| CA2343893C (en) | 1998-09-15 | 2008-12-30 | Biophoretic Therapeutic Systems, Llc | Iontophoretic drug delivery electrodes |
| AU4053700A (en) * | 1999-04-02 | 2000-10-23 | Washington State University Research Foundation | Enhanced tissue and subcellular delivery of vitamin e compounds |
| AU2002306342A1 (en) | 2002-06-10 | 2003-12-22 | The Kitasato Institute | Inhibitors against complex ii of electron transport system |
| US20040175415A1 (en) | 2003-03-05 | 2004-09-09 | Chan Alvin C. | Formulations and methods of delivery of intact tocopheryl succinate to humans |
| US6716873B1 (en) | 2003-03-20 | 2004-04-06 | Yasoo Health Inc. | Tocopherol ester compounds |
| WO2006015120A2 (en) | 2004-07-28 | 2006-02-09 | Sd Pharmaceuticals, Inc. | Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof |
| WO2006086798A2 (en) * | 2005-02-08 | 2006-08-17 | Board Of Regents, The University Of Texas System | Compositions and methods involving mda-7 for the treatment of cancer |
-
2007
- 2007-09-17 KR KR1020097007629A patent/KR101482803B1/ko not_active Expired - Fee Related
- 2007-09-17 AU AU2007295877A patent/AU2007295877B2/en active Active
- 2007-09-17 US US12/441,487 patent/US8410056B2/en not_active Expired - Fee Related
- 2007-09-17 JP JP2009527656A patent/JP5396274B2/ja not_active Expired - Fee Related
- 2007-09-17 EP EP07800325.8A patent/EP2063884B1/en active Active
- 2007-09-17 WO PCT/AU2007/001371 patent/WO2008031171A1/en not_active Ceased
- 2007-09-17 CA CA2663474A patent/CA2663474C/en active Active
- 2007-09-17 NZ NZ575920A patent/NZ575920A/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010508242A5 (enExample) | ||
| Tan et al. | Glabridin, a bioactive component of licorice, ameliorates diabetic nephropathy by regulating ferroptosis and the VEGF/Akt/ERK pathways | |
| Gao et al. | Urolithin A protects against acetaminophen-induced liver injury in mice via sustained activation of Nrf2 | |
| BA Djamgoz et al. | Persistent current blockers of voltage-gated sodium channels: a clinical opportunity for controlling metastatic disease | |
| BRPI0515477A (pt) | derivados heterocìclicos bicìclicos e o uso dos mesmos como inibidores de estaroil-coa-desaturase (scd) | |
| WO2008080082A3 (en) | Methods for modulating set and uses thereof | |
| BRPI0515500A (pt) | derivados piridazina para inibição de estearoil-coa-desaturase | |
| BRPI0509172A (pt) | pelo menos uma entidade quìmica, composição farmacêutica, métodos para tratar um paciente, para inibir pelo menos uma enzima que utiliza atp, e para tratar pelo menos uma doença, uso de pelo menos uma entidade quìmica, e, método para a fabricação de um medicamento | |
| EA200971041A1 (ru) | Новые пептидные ингибиторы репликации вируса гепатита с | |
| BRPI0515489A (pt) | derivados heterocìclicos e sua utilização como inibidores de estearoil-coa desaturase | |
| CL2007001388A1 (es) | Co-cristal de maleato de 2{etil[3-({4-[(5-{2-[(3-fluorfenil)amino]-2-oxoetil}-1h-pirazol-3-il)amino]quinazolin-7-il}oxi)propil]amino}fosfato dihidrogeno de etilo (azd1152), inhibidor de aurora quinasa; metodo de preparacion; composicion farmaceutica; y uso para el tratamiento de enfermedades hiperproliferativas como el cancer. | |
| BR0214386A (pt) | Método para identificação de enzimas de objetivação a tumor | |
| Bae et al. | Inhaled essential oil from Chamaecyparis obtuse ameliorates the impairments of cognitive function induced by injection of β-amyloid in rats | |
| BRPI0417260A (pt) | derivados de azepinoindol como agentes farmacêuticos | |
| BRPI0510599A (pt) | compostos, processo para a preparação dos mesmos, composição farmacêutica, uso de um composto, e método para o tratamento e a profilaxia de doenças | |
| Wu et al. | The role of endoplasmic reticulum stress in endothelial dysfunction induced by homocysteine thiolactone | |
| Liu et al. | β-elemene enhances the radiosensitivity of gastric cancer cells by inhibiting Pak1 activation | |
| BRPI0515577A (pt) | compostos de carbonila que podem ser empregados como inibidores de fator xa de coagulação | |
| BRPI0411098A (pt) | benzofuranocarboxamidas, com atividade pi3k, como agentes terapêuticos | |
| BR0316550A (pt) | Composto, composição farmacêutica, e, métodos para tratar ou prevenir câncer em um paciente, e para detectar câncer em um paciente | |
| EA200601846A1 (ru) | Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей | |
| TR200401669T1 (tr) | Neoplastik hastalıkların tedavisi için metarix-metalloproteinazları önleyen kompozisyon. | |
| Büyükokuroğlu et al. | Dantrolene may prevent organophosphate-induced oxidative stress and muscle injury | |
| BR0315942A (pt) | Tratamento de doenças e condições mediadas pelo aumento de fosforilação | |
| BRPI0414736A (pt) | 5-aril-pirimidinas como agentes anticáncer |